Literature DB >> 21898133

Solalyratins A and B, new anti-inflammatory metabolites from Solanum lyratum.

De-Wu Zhang1, Yan Yang, Fang Yao, Qun-Ying Yu, Sheng-Jun Dai.   

Abstract

A new coumestan (solalyratin A, 1) and a novel cyclic eight-membered α,β-unsaturated ketone (solalyratin B, 3), together with three known compounds, puerariafuran (2), coumestrol (4) and 9-hydroxy-2',2'-dimethylpyrano[5',6':2,3]-coumestan (5), were isolated from the whole plant of Solanum lyratum. Their structures were elucidated on the basis of spectroscopic analyses. In vitro, compounds 1-5 showed anti-inflammatory activities, with IC(50) values in the range 6.3-9.1 μM.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21898133     DOI: 10.1007/s11418-011-0581-3

Source DB:  PubMed          Journal:  J Nat Med        ISSN: 1340-3443            Impact factor:   2.343


  14 in total

1.  New anti-inflammatory 4-hydroxyisoflavans from Solanum lyratum.

Authors:  De-Wu Zhang; Gui-Hai Li; Qun-Ying Yu; Sheng-Jun Dai
Journal:  Chem Pharm Bull (Tokyo)       Date:  2010-06       Impact factor: 1.645

2.  Puerariafuran, a new inhibitor of advanced glycation end products (AGEs) isolated from the roots of Pueraria lobata.

Authors:  Dae Sik Jang; Jong Min Kim; Yun Mi Lee; Young Sook Kim; Joo-Hwan Kim; Jin Sook Kim
Journal:  Chem Pharm Bull (Tokyo)       Date:  2006-09       Impact factor: 1.645

3.  Coumestans from Hedysarum multijugum.

Authors:  Wei Wang; Yu-Ying Zhao; Hong Liang; Qi Jia; Hu-Biao Chen
Journal:  J Nat Prod       Date:  2006-06       Impact factor: 4.050

4.  Caspase and mitogen activated protein kinase pathways are involved in Solanum lyratum herba induced apoptosis.

Authors:  Jin-Hyuk Lee; Yun-Hee Lee; Hyo-Jung Lee; Hyo-Jeong Lee; Eun-Ok Lee; Kwang Seok Ahn; Bum Sang Shim; Hyunsu Bae; Seung-Hoon Choi; Kyoo-Seok Ahn; Nam-In Baek; Dae-Keun Kim; Sung-Hoon Kim
Journal:  J Ethnopharmacol       Date:  2009-02-20       Impact factor: 4.360

5.  Two new sesquiterpenoids from Solanum lyratum with cytotoxic activities.

Authors:  Yan Ren; Li Shen; De-Wu Zhang; Sheng-Jun Dai
Journal:  Chem Pharm Bull (Tokyo)       Date:  2009-04       Impact factor: 1.645

6.  Solanum lyratum inhibits anaphylactic reaction and suppresses the expression of L-histidine decarboxylase mRNA.

Authors:  H M Kim; E J Lee
Journal:  Immunopharmacol Immunotoxicol       Date:  1998-02       Impact factor: 2.730

7.  Solanum lyratum extract affected immune response in normal and leukemia murine animal in vivo.

Authors:  Jai-Sing Yang; Chia-Chun Wu; Chao-Lin Kuo; Chin-Chung Yeh; Fu-Shin Chueh; Cheng-Kuang Hsu; Chien-Kuo Wang; Ching-Yao Chang; Siu-Wan Ip; Yuan-Man Hsu; Wei-Wen Kuo; Jing-Gung Chung
Journal:  Hum Exp Toxicol       Date:  2010-03-02       Impact factor: 2.903

8.  Crude extracts of Solanum lyratum protect endothelial cells against oxidized low-density lipoprotein-induced injury by direct antioxidant action.

Authors:  Wei-Wen Kuo; Chih-Yang Huang; Jing-Gung Chung; Shun-Fa Yang; Kun-Ling Tsai; Tsan-Hung Chiu; Shin-Da Lee; Hsiu-Chung Ou
Journal:  J Vasc Surg       Date:  2009-08-22       Impact factor: 4.268

9.  Evaluation of anti-inflammatory activity of some Swedish medicinal plants. Inhibition of prostaglandin biosynthesis and PAF-induced exocytosis.

Authors:  H Tunón; C Olavsdotter; L Bohlin
Journal:  J Ethnopharmacol       Date:  1995-10       Impact factor: 4.360

10.  Crude extracts of Solanum lyratum induced cytotoxicity and apoptosis in a human colon adenocarcinoma cell line (colo 205).

Authors:  Shu-Chun Hsu; Jih-Hung Lu; Chao-Lin Kuo; Jai-Sing Yang; Meng-Wei Lin; Guang-Wei Chen; Chin-Cheng Su; Hsu-Fung Lu; Jing-Gung Chung
Journal:  Anticancer Res       Date:  2008 Mar-Apr       Impact factor: 2.480

View more
  2 in total

1.  Chakyunglupulins A and B, two novel 4,8,8-trimethylcyclooct-2-enone derivatives from Barleria lupulina.

Authors:  Ki Hyun Kim; Jon Clardy; Donald Senger; Shugeng Cao
Journal:  Tetrahedron Lett       Date:  2015-05-20       Impact factor: 2.415

2.  Toxicological Safety Evaluation in Acute and 21-Day Studies of Ethanol Extract from Solanum lyratum Thunb.

Authors:  XiaoHua Guo; LianJin Weng; LiTao Yi; Di Geng
Journal:  Evid Based Complement Alternat Med       Date:  2022-03-31       Impact factor: 2.629

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.